Moreover, AD-patients treated with cells releasing nerve growth factor (NGF) in the basal forebrain (Eriksdotter-Jönhagen et al., 2012) also showed changes in the CSF levels of ChAT and AChE (Karami et al., 2015). The gene discussed is CHAT; the disease is Alzheimer disease.